SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : PFE (Pfizer) How high will it go?
PFE 24.90-0.4%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rob Loney who wrote (468)1/27/1998 5:31:00 AM
From: James Baker  Read Replies (1) of 9523
 
<<<With 50% of Lipitor sales worldwide going to Pfizer>>>
Rob,
My understanding and recent Barron's article indicate that the WLA/PFE deal concerning revenue and earnings has never been reported publically. Barron's actually says that payments to PFE come only after sales reach certain unspecified level. WLA owns the patent on Lipitor and it seems likely that WLA will be getting more benefit from sales than PFE. Can you cite a source for other info?
Long PFE but wants the facts - not hype.
Jim
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext